FDA Adverse Event Malfunction Summary report: N

ZENITH ALPHA THORACIC ENDOVASCULAR GRAFT PROXIMAL COMPONENTS

MDR report key: 23955821 · Received January 5, 2026

Report

Report Number
3002808486-2026-00003
Event Type
Malfunction
Date Received
January 5, 2026
Date of Event
December 23, 2025
Report Date
May 11, 2026
Manufacturer
WILLIAM COOK EUROPE
Product Code
MIH
UDI-DI
00827002449435
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MANUFACTURERS REF# (B)(4). G4) SIMILAR TO DEVICE MARKETED UNDER 510(K)/PMA: P140016. INVESTIGATION IS STILL IN PROGRESS. THIS REPORT IS REQUIRED BY THE FDA UNDER 21 CFR PART 803. THIS REPORT IS BASED ON UNCONFIRMED INFORMATION SUBMITTED BY OTHERS. NEITHER THE SUBMISSION OF THIS REPORT NOR ANY STATEMENT MADE IN IT IS INTENDED TO BE AN ADMISSION THAT ANY COOK DEVICE IS DEFECTIVE OR MALFUNCTIONED; THAT A DEATH OR SERIOUS INJURY OCCURRED; OR THAT ANY COOK DEVICE CAUSED OR CONTRIBUTED TO; OR IS LIKELY TO CAUSE OR CONTRIBUTE TO A DEATH OR SERIOUS INJURY IF A MALFUNCTION OCCURRED.

Description of Event or Problem · 0

DESCRIPTION OF EVENT ACCORDING TO INITIAL REPORTER: APPROACH: RIGHT FEMORAL ARTERY (FA) ANATOMY: VASCULAR GRAFT WITH STENOSIS AND TORTUOSITY THE CASE WAS AN EMERGENCY PROCEDURE. DURING DELIVERY, RESISTANCE WAS ENCOUNTERED WITHIN THE GRAFT. DESPITE MULTIPLE ATTEMPTS, THE DEVICE COULD NOT CROSS THE GRAFT. UPON WITHDRAWAL, INSPECTION REVEALED A POSITIONAL GAP BETWEEN THE SHEATH TIP AND THE DILATOR, AND THE SHEATH TIP WAS BULGING. CONSIDERING SAFE USE, A BACKUP DEVICE OF THE SAME SPECIFICATION WAS UTILIZED, WHICH WAS SUCCESSFULLY DELIVERED AND DEPLOYED WITHOUT ANY ISSUES. PATIENT OUTCOME: NO HEALTH HAZARDS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
618847 ZENITH ALPHA THORACIC ENDOVASCULAR GRAFT PROXIMAL COMPONENTS MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH WILLIAM COOK EUROPE G44943 E4369809 00827002449435

Patients

Seq Age Sex Outcome Treatment
1